Concepedia

Daniel Ursu

DU

27

Publications

1.6K

Citations

21

H-Index

2001

Active since

Affiliations

Eli Lilly (United Kingdom)(Current)

Universität Ulm

Eli Lilly (United States)

Saarland University

University College London

Daniel Ursu is an author at Eli Lilly (United Kingdom) specializing in medicine, physiology, and pharmacology.

ORCID

Top concepts

Publications per year

2001–2019

27

Publications

27

Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice

Martin M. Jendryka, Monika Palchaudhuri, Daniel Ursu et al. · Scientific Reports · 2019 · 312 citations · Full text

A mutation in the GABA<sub>A</sub> receptor α<sub>1</sub>‐subunit is associated with absence epilepsy

Snezana Maljevic, Klaus Krampfl, Joana Cobilanschi et al. · Annals of Neurology · 2006 · 205 citations

Passive muscle stiffness may be influenced by active contractility of intramuscular connective tissue

Robert Schleip, I.L. Naylor, Daniel Ursu et al. · Medical Hypotheses · 2005 · 166 citations

, , +11

Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and agonist potency – molecular profiling and functional rescue

Laura Addis, Jasmeet Virdee, Lewis R. Vidler et al. · Scientific Reports · 2017 · 93 citations · Full text

Gain and Loss of Function of P2X<sub>7</sub> Receptors: Mechanisms, Pharmacology and Relevance to Diabetic Neuropathic Pain

Daniel Ursu, Philip J. Ebert, Emily Langron et al. · Molecular Pain · 2014 · 78 citations · Full text

Rows per page

1–5 of 27